期刊文献+

临床药师参与1例重症胰腺炎患者营养支持的案例分析 被引量:3

Clinical pharmacists participate a case analysis of nutrition support therapy for a patient with severe acute pancreatitis
下载PDF
导出
摘要 目的:探讨临床药师在重症急性胰腺炎患者个体化营养支持治疗中的作用。方法:通过1例重症急性胰腺炎案例,分析患者肠内营养不耐受的原因并采取相应对策,结合患者病理生理特点制定个体化肠外营养支持方案。结果与结论:临床药师应对重症急性胰腺炎患者的营养支持开展全程化的药学监护,及时调整营养支持方式,调节患者营养状态,改善患者预后。 Objective: To explore the role of clinical pha---cmacists in individual nutrition support therapy for severe acute pancreatitis patients. Methods: A case of clinical nutritional therapy for a severe acute pancreatitis patient who had intolerance with enteral nutrition was analyzed and individualized nutritional therapy was applied based on pathophysiologic characteristic. Results & Conclusion: Pharmaceutical care of clinical nutrition therapy for a severe acute pancreatitis patient was carried out by clinical pharmacists in the whole process. Patient prognosis was improved by timely adjustment of nutritional support and nutritional status of patient.
出处 《上海医药》 CAS 2017年第17期65-68,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 临床药师 重症急性胰腺炎 营养治疗 clinical pharmacist severe acute pancreatitis nutrition support therapy
  • 相关文献

参考文献1

二级参考文献12

  • 1中国肥胖问题工作组.中国成人超重和肥胖症预防控制指南(试行)2003版.
  • 2Bao Y,Lu J,Wang C,et al.Optimal waist circumference cutoffs for abdominal obesity in Chinese.Atherosclerosis,2008,201:378-384.
  • 3Dong X,Liu Y,YangJ,et al.Efficiency of anthropometric indicators of obesity for identifying cardiovascular risk factors in a Chinese population.Postgrad Med J,2011,87:251-256.
  • 4Xu F,Wang YF,Lu L,et al.Comparison of anthropometric indices of obesity in predicting subsequent risk of hyperglycemia among Chinese men and women in China's Mainland.Asia Pac J Clin Nutr,2010,19:586-593.
  • 5Shi XD,He SM,Tao YC,et al.Prevalence of obesity and associated risk factors in Northeastern China.Diabetes Res Clin Pract,2011,91:389-394.
  • 6Tsigosa C,Hainer V,Basdevant A,et al.Management of obesity in adults:European clinical practice guidelines.Obes Facts,2008,1:106-116.
  • 7The NICE Clinical Guideline CG43: Obesity: the prevention,identification,assessment and management of overweight and obesity in adults and children.www.nice.org.uk/guidance/index.jsp? action =byID&o =11000.
  • 8National Institutes of Health (NIH),National Heart,Lung,and Blood Institute (NHLBI):The practical guide:identification,evaluation,and treatment of overweight and obesity in adults.Bethesda,National Institutes of Health,2000; NIH publication 00-4084.www.nhlbi.nih.goy/guidelines/obesity/ob_home.htm.
  • 9Lau DC,Douketis JD,Morrison KM,et al.2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children[summary] .CAMJ,2007,176 (suppl 8):S1-S13.
  • 10Astrup A,R(o)ssner S,Van Gaal L,et al.Effects of liraglutide in the treatment of obesity:a randomised,double-blind,placebo-controlled study.Lancet,2009,374:1606-1616.

共引文献588

同被引文献30

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部